7-150951512-G-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000238.4(KCNH2):c.1881C>A(p.Phe627Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. F627F) has been classified as Likely benign.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.1881C>A | p.Phe627Leu | missense_variant | Exon 7 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The Phe627Leu mutation in the KCNH2 gene has been published previously in association with LQTS (1-3). Phe627Leu, located in the pore region of the protein, has been reported in individuals with LQTS who harbored a different nucleotide substitution which resulted in the same Phe627Leu protein change as this patient (c.1879 T>C and c.1881 C>G, respectively). Lin et al. (2008) reported a 25-week fetus with intermittent AV block due to an extremely long QT interval who harbored the Phe627Leu mutation in the KCNH2 gene, as well as a missense mutation in the SCN5A gene. Another mutation affecting the same residue (Phe627Ile) as well as neighboring residues (Val625Glu, Gly626Ala, Gly626Asp, Gly626Ser, Gly626Val, Gly628Ala, Gly628Ser, Gly628Val) have also been reported in association with LQTS, further supporting the functional importance of this residue and this region of the protein. Phe627Leu was not detected in over 400 control chromosomes reported in the literature, nor in up to 400 control chromosomes of African American and Caucasian ancestry tested at GeneDx, indicating it is not a common benign polymorphism in these populations. Therefore, the presence of the Phe627Leu mutation in the KCNH2 gene is consistent with a diagnosis of an autosomal dominant form of LQTS. The variant is found in LQT panel(s). -
Long QT syndrome Pathogenic:1
This missense change has been observed in individual(s) with clinical features of long QT syndrome (PMID: 24322056, 24217263, 18848812, 11854117). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 200747). This missense change has been reported to affect KCNH2 protein function (PMID: 25417810, 18848812). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (ExAC no frequency). This sequence change replaces phenylalanine with leucine at codon 627 of the KCNH2 protein (p.Phe627Leu). The phenylalanine residue is highly conserved and there is a small physicochemical difference between phenylalanine and leucine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at